Antipsychotic drugs and venous thromboembolism

Case reports and observational studies have suggested that patients who take antipsychotic drugs have an increased risk of venous thromboembolism (VTE). Using a case-control design, Zornberg and Jick (Lancet 2000 356:1219-1223) evaluated patterns of conventional antipsychotic drug use in 42 patients suffering a first idiopathic VTE (cases) and 168 patients matched for factors including age, sex and index date (controls); all patients had filled at least one prescription for an antipsychotic drug

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

Case reports and observational studies have suggested that patients who take antipsychotic drugs have an increased risk of venous thromboembolism (VTE). Using a case-control design, Zornberg and Jick (Lancet 2000 356:1219-1223) evaluated patterns of conventional antipsychotic drug use in 42 patients suffering a first idiopathic VTE (cases) and 168 patients matched for factors including age, sex and index date (controls); all patients had filled at least one prescription for an antipsychotic drug and were younger than 60 years of age.

Compared with patients who had not filled a prescription within 120 days of the index event, patients who had filled a prescription within 60 days of the index date had a much greater risk of idiopathic VTE (adjusted odds ratio, 7.1; 95% confidence interval, 2.3 to 21.97). The risk was similar for individual drugs. However, the risk differed according to the class of drug and was particularly high for the ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
Share
Illustration of a developing fetus surrounded by a clear fluid with a subtle yellow tinge, representing amniotic fluid.
January 2026

What Is the Amniotic Fluid Composed of?

The liquid world of fetal development provides a rich source of nutrition and protection tailored to meet the needs of the growing fetus.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies

Parse Logo

Parse Biosciences and Graph Therapeutics Partner to Build Large Functional Immune Perturbation Atlas

Sino Biological Logo

Sino Biological's Launch of SwiftFluo® TR-FRET Kits Pioneers a New Era in High-Throughout Kinase Inhibitor Screening

SPT Labtech Logo

SPT Labtech enables automated Twist Bioscience NGS library preparation workflows on SPT's firefly platform